Genetic diagnosis of Duchenne and Becker muscular dystrophy through mRNA analysis: new splicing events.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36535754.
- Also identified by DOI 10.1136/jmg-2022-108828 and PMC identifier 10313949.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Up to 7% of patients with Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD) remain genetically undiagnosed after routine genetic testing. These patients are thought to carry deep intronic variants, structural variants or splicing alterations not detected through multiplex ligation-dependent probe amplification or exome sequencing. RNA was extracted from seven muscle biopsy samples of patients with genetically undiagnosed DMD/BMD after routine genetic diagnosis. RT-PCR of the <i>DMD</i> gene was performed to detect the presence of alternative transcripts. Droplet digital PCR and whole-genome sequencing were also performed in some patients. We identified an alteration in the mRNA level in all the patients. We detected three pseudoexons in <i>DMD</i> caused by deep intronic variants, two of them not previously reported. We also identified a chromosomal rearrangement between Xp21.2 and 8p22. Furthermore, we detected three exon skipping events with unclear pathogenicity. These findings indicate that mRNA analysis of the <i>DMD</i> gene is a valuable tool to reach a precise genetic diagnosis in patients with a clinical and anatomopathological suspicion of dystrophinopathy that remain genetically undiagnosed after routine genetic testing.
Medical subject headings
- Muscular Dystrophy, Duchenne